Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sana Biotechnology (SANA)
NASDAQ:SANA
Holding SANA?
Track your performance easily
SANA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.75 - $12.00
Previous Close$4.3
Volume1.59M
Average Volume (3M)1.71M
Market Cap
$956.60M
Enterprise Value$803.52M
Total Cash (Recent Filing)$251.64M
Total Debt (Recent Filing)$98.56M
Price to Earnings (P/E)―
Beta2.52
Next Earnings
Nov 05, 2024EPS Estimate
-$0.28Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.15
Shares Outstanding222,465,934
10 Day Avg. Volume1,395,760
30 Day Avg. Volume1,714,044
Standard Deviation0.26
R-Squared0.07
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)2.85
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-4.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-4.82
Forecast
1Y Price Target
$14.25Price Target Upside232.17% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Sana Biotechnology News
Bulls Say, Bears Say
Bulls Say
Clinical DevelopmentEncouraging preliminary trial results show a 75% overall response rate for SC291 without critical safety concerns, supporting the stock's potential.
Financial StabilitySana has a solid cash position of $311.1MM, indicating financial stability for ongoing operations and research.
Product PipelineExpansion of SC291 into autoimmune diseases targets unmet medical needs, indicating a broader market opportunity for Sana Biotechnology.
Bears Say
Cost ManagementSana's higher than expected SG&A expenses indicate inefficient cost management and could pressure profitability.
Financial PerformanceSana reported no revenues for the fourth quarter, highlighting a lack of sales and income generation.
Stock ValuationAnalysts anticipate a significant share price decline for Sana, reflecting a negative outlook on the stock's future performance.
---
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
SANA FAQ
What was Sana Biotechnology’s price range in the past 12 months?
Sana Biotechnology lowest stock price was $2.75 and its highest was $12.00 in the past 12 months.
What is Sana Biotechnology’s market cap?
Currently, no data Available
When is Sana Biotechnology’s upcoming earnings report date?
Sana Biotechnology’s upcoming earnings report date is Nov 05, 2024 which is in 46 days.
How were Sana Biotechnology’s earnings last quarter?
Sana Biotechnology released its earnings results on Aug 08, 2024. The company reported -$0.21 earnings per share for the quarter, beating the consensus estimate of -$0.292 by $0.082.
Is Sana Biotechnology overvalued?
According to Wall Street analysts Sana Biotechnology’s price is currently Undervalued.
Does Sana Biotechnology pay dividends?
Sana Biotechnology does not currently pay dividends.
What is Sana Biotechnology’s EPS estimate?
Sana Biotechnology’s EPS estimate is -$0.28.
How many shares outstanding does Sana Biotechnology have?
Sana Biotechnology has 222,465,930 shares outstanding.
What happened to Sana Biotechnology’s price movement after its last earnings report?
Sana Biotechnology reported an EPS of -$0.21 in its last earnings report, beating expectations of -$0.292. Following the earnings report the stock price went up 5.365%.
Which hedge fund is a major shareholder of Sana Biotechnology?
Among the largest hedge funds holding Sana Biotechnology’s share is Flagship Pioneering Inc.. It holds Sana Biotechnology’s shares valued at 137M.
---
Sana Biotechnology Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$14.25 (232.17% Upside)
$14.25 (232.17% Upside)
Blogger Sentiment
Neutral
SANA Sentiment 50%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 1.2M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 4.2%
Last 30 Days ▼ 7.3%
Last 30 Days ▼ 7.3%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-3.80%
12-Months-Change
Fundamentals
Return on Equity
-70.51%
Trailing 12-Months
Asset Growth
-12.51%
Trailing 12-Months
Company Description
Sana Biotechnology
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases.
---
SANA Stock 12 Month Forecast
Average Price Target
$14.25
▲(232.17% Upside)
Technical Analysis
Fate Therapeutics
―
Editas Medicine
―
Intellia Therapeutics
―
BioMarin Pharmaceutical
―
Best Analysts Covering SANA
1 Year
1 Year Success Rate
3/6 ratings generated profit
1 Year Average Return
+18.42%
reiterated a buy rating 4 months ago
Copying Geoff Meacham's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +18.42% per trade.
---